Drug intelligence / Profile preview

human allogeneic hepatic cells

Development stage
Preclinical
Lead developer
Promethera Therapeutics
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intraportal Infusion, Intrahepatic, Intraperitoneal
01

Overview

Human allogeneic hepatic cells are viable liver cells (hepatocytes) isolated from the livers of human donors and intended for transplantation into another individual. These cells are used as a form of cell therapy to treat various liver diseases, particularly in cases where whole-organ transplantation is not feasible or available. The mechanism involves engraftment and functional integration of the transplanted hepatocytes into the recipient's liver, providing metabolic support or replacing deficient enzymatic activity. This approach is being explored for acute liver failure, inherited metabolic disorders affecting the liver, and other severe hepatic conditions[2][3]. The primary therapeutic effect comes from restoring lost or deficient hepatic functions through direct cellular replacement.

Other names
human allogeneic hepatocytesdonor-derived human liver cells

Beyond the preview

Go deeper on human allogeneic hepatic cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human allogeneic hepatic cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call